September 07, 2026 08:10 pm (IST)
Zydus Cadila receives USFDA approval to market Carboplatin Injection
Ahmedabad, Apr 1 (IBNS) Zydus Cadila, a fully integrated, global healthcare provider, announced on Friday that it has received the final approval from the USFDA to market Carboplatin Injection, 10 mg/ml in 5 ml, 15 ml and 45 ml.
The group now has more than 100 approvals and has so far filed over 280 ANDAs since the commencement of the filing process in FY 2003-04.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
Adani Power Improves ESG Score to 66 in NSE Sustainability Assessment. What does it mean?
Mon, Sep 07 2026
Bajaj Broking launches its ChatGPT plugin to help users with AI-powered portfolio insights. Why is it needed?
Mon, Sep 07 2026
TCS’ HyperVault to establish large-scale AI data center campus in Telangana: Know all details
Sun, Sep 06 2026
Is This the Right Time to Lock Your Savings in an FCNR Deposit?
Sat, Sep 05 2026
Thales and Kalyani Strategic Systems Limited sign Strategic Alliance Agreement for 70-mm Rocket Systems
Fri, Sep 04 2026
Axis Bank and Scapia launch co-branded credit card for India's new generation of travellers
Fri, Sep 04 2026
What is MillionR Special Edition? TVS Motor celebrates one million TVS iQube families. All you need to know
Fri, Sep 04 2026
